VYGR Voyager Therapeutics, Inc.: institutional ownership and insider trading
139 funds reported holding $138M of Voyager Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $6.28M, with 19 new positions and 16 funds selling out; over the last 12 months insiders bought $0 and sold $298K on the open market; over its last four quarters it reported revenue of $34.5M and net income of −$108M.
VYGR revenue and earnings
- Quarter ended Jun 30, 2026: revenue $3.17M, net income −$24.5M, EPS -0.40
- Quarter ended Mar 31, 2026: revenue $2.59M, net income −$27.9M, EPS -0.47
- Quarter ended Dec 31, 2025: revenue $15.3M, net income −$27.4M, EPS -0.47
- Quarter ended Sep 30, 2025: revenue $13.4M, net income −$27.9M, EPS -0.47
Famous investors holding VYGR
- Izzy Englander (Millennium Management): $15.6M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $3.32M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $3.12M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $1.73M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $504K, 0.0% of the portfolio
Largest institutional holders of VYGR
- BlackRock, Inc. (BLK) — $18.1M
- MILLENNIUM MANAGEMENT LLC — $15.6M
- VANGUARD GROUP INC — $12.8M
- ARMISTICE CAPITAL, LLC — $12.0M
- Vestal Point Capital, LP — $9.19M
- VANGUARD CAPITAL MANAGEMENT LLC — $8.21M
- GEODE CAPITAL MANAGEMENT, LLC — $4.66M
- Opaleye Management Inc. — $4.15M
- STATE STREET CORP (STT, STT-PG) — $3.77M
- TWO SIGMA INVESTMENTS, LP — $3.32M
Recent VYGR insider trades
- Apr 2, 2026: Sandrock Alfred sold 11,511 shares ($44.5K)
- Feb 24, 2026: Carter Todd Alfred sold 4,174 shares ($15.7K)
- Feb 24, 2026: Jorgensen Nathan D. sold 4,668 shares ($17.6K)
- Feb 24, 2026: Sandrock Alfred sold 14,197 shares ($53.8K)
5%+ owners
- Millennium Management LLC: 7.4% (Schedule 13G/A, filed Jul 31, 2026)
- Armistice Capital, LLC: 5.6% (Schedule 13G/A, filed Aug 14, 2026)
Who owns the most VYGR stock?
The largest institutional holders of Voyager Therapeutics, Inc. in the latest 13F filings are BlackRock, Inc. (BLK) ($18.1M), MILLENNIUM MANAGEMENT LLC ($15.6M), VANGUARD GROUP INC ($12.8M).
Are insiders buying or selling VYGR?
Over the last 12 months insiders bought $0 and sold $298K of Voyager Therapeutics, Inc. stock on the open market (SEC Form 4).
Which famous investors own VYGR?
Izzy Englander, Two Sigma, Ken Griffin, Renaissance Technologies, D. E. Shaw.
What was VYGR's revenue last quarter?
Voyager Therapeutics, Inc. reported revenue of $3.17M for the quarter ended June 30, 2026, with net income of −$24.5M.
Which ETFs hold VYGR?
1 ETFs and mutual funds hold it among their top 100 positions, including IBRN.